Oscar Health, a prominent player in the health insurance industry, has been making waves in the financial world. Recently, four analysts have published their ratings on the company, sparking a mix of bullish and bearish sentiments among investors. In this article, we will delve into the shifting sentiments over the past 30 days and explore the 12-month price targets set by these analysts.

According to the data, none of the analysts have given bullish or indifferent ratings, while one analyst has provided a somewhat bearish rating in the last 30 days. The same period has seen two somewhat bearish and one bearish rating. The ratings from the previous months also reveal an inconsistent trend, with a majority of ratings leaning towards the bearish side.

The analysts have also evaluated Oscar Health and provided 12-month price targets. The average target price stands at $26.5, with a high estimate of $28.00 and a low estimate of $25.00. This upward trend is noteworthy, with the current average reflecting a 1.92% increase from the previous average price target of $26.00. This rise in price targets indicates a growing confidence among analysts in Oscar Health's potential for growth.

Jessica Tassan from Piper Sandler is one of the analysts who has recently evaluated Oscar Health. Tassan has maintained her overweight rating and set a price target of $28.00, which is the highest among all analysts. Her previous price target was also $28.00, indicating that she remains confident in the company's prospects. However, it's worth noting that Tassan had previously raised her price target from $25.00 to $28.00, showcasing her growing confidence in the company.

So, what do these analyst actions mean for investors? In examining recent analyst actions, we gain valuable insights into how financial experts perceive Oscar Health. These insights can help investors make informed decisions about their investment strategies. Whether analysts choose to maintain, raise, or lower their stance, it can signal a shift in market sentiment. In this case, the upward trend in price targets suggests that analysts are becoming increasingly bullish on Oscar Health's prospects.

However, it's essential to consider multiple perspectives before making any investment decisions. A thorough analysis of the company's financials, market trends, and competitive landscape is necessary to determine the best course of action. Nevertheless, the recent analyst evaluations and price targets provide a compelling case for Oscar Health's potential for growth.